Royalty Pharma RPRX
NASDAQ RPRX
$69.31 +0.34 (+0.49%)
At close: Nov 13, 2026 · 4:00 PM EST

Royalty Pharma (RPRX) Securities - Available for Sale (2019 - 2025)

Updated

Royalty Pharma (RPRX) recorded Securities - Available for Sale of $428.7 million in Q4 2025, down 42.0% from $739.62 million a year earlier but up 39.4% from the prior quarter.

Analysis

Royalty Pharma (RPRX) Securities - Available for Sale (2019 - 2025) Analysis & Trends

Starting with Q2 2019, Royalty Pharma's Securities - Available for Sale history includes 26 quarters.

  • Annual Securities - Available for Sale has a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
  • Across earlier years, Securities - Available for Sale came in at $739.62 million in FY2024 (+62.7%), $454.5 million in FY2023 (+101.9%), $225.1 million in FY2022 (-16.8%) and $270.4 million in FY2021 (+16.1%).
  • Quarterly Securities - Available for Sale has ranged from $213.2 million in Q1 2025 to $739.62 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Securities - Available for Sale has declined for four consecutive quarters, with growth averaging 16.6% over the last eight quarters.
  • Peak year-over-year performance for Securities - Available for Sale in the last five years was growth of 189.1% in Q3 2022, against a decline of 60.1% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $307.5 million (Q3 2025), $257.9 million (Q2 2025) and $213.2 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Securities - Available for Sale (Qtr)
1 Royalty Pharma 39.80 Bn 40.13 Bn - -
2 Rocket Companies 38.90 Bn 27.72 Bn - -
3 Orix 38.66 Bn 9.30 Bn 13.83 Bn -
4 Federal National Mortgage Association Fannie Mae 26.46 Bn -16,107.65 Bn - -
5 Synchrony Financial 22.47 Bn -45.15 Bn - 4.36 Bn
6 Affirm Holdings 22.07 Bn 15.11 Bn - -
7 Royal Gold 21.71 Bn 20.92 Bn 402.46 Mn -
8 Ares Capital 13.84 Bn 11.59 Bn - -
9 Annaly Capital Management 13.83 Bn 4.86 Bn - 86.90 Bn
10 Federal Home Loan Mortgage 12.64 Bn -328.33 Bn - 2.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 428.70 Mn
Sep 30, 2025 307.50 Mn
Jun 30, 2025 257.90 Mn
Mar 31, 2025 213.20 Mn
Dec 31, 2024 739.62 Mn
Sep 30, 2024 701.20 Mn
Jun 30, 2024 646.40 Mn
Mar 31, 2024 499.48 Mn
Dec 31, 2023 454.50 Mn
Sep 30, 2023 347.60 Mn
Jun 30, 2023 340.30 Mn
Mar 31, 2023 257.40 Mn
Dec 31, 2022 225.10 Mn
Sep 30, 2022 739.25 Mn
Jun 30, 2022 383.00 Mn
Mar 31, 2022 304.40 Mn
Dec 31, 2021 270.40 Mn
Sep 30, 2021 255.70 Mn
Jun 30, 2021 271.20 Mn
Mar 31, 2021 249.20 Mn
API Access

Royalty Pharma Securities - Available for Sale API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=securities-available-for-sale&ticker=RPRX&period=max&api_key=YOUR_API_KEY